Laura T. Morton - Concepedia

Author

Laura T. Morton

Leiden University Medical Center ORCID

Also Known As

Laura Morton, Laura T Morton, Laura T. Morton

Publications

504

Citations

H-Index

Concepts

All Affiliations

Leiden University Medical Center University of Birmingham Immune Regulation (United Kingdom)

About

Laura T. Morton is an author at Leiden University Medical Center specializing in medicine, immunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	179
2	Cell Biology	2	2	179
3	Immunology	2	2	179
4	Autoimmunity	1	1	100
5	Cell Signaling	1	1	100

Laura T. Morton

Publications

435

Citations

H-Index

Page 1

	Year	Citations
MHC II tetramers visualize human CD4+ T cell responses to Epstein–Barr virus infection and demonstrate atypical kinetics of the nuclear antigen EBNA1 response Heather M. Long, Odette Chagoury, Alison M. Leese, The Journal of Experimental Medicine	2013	121
A Jurkat 76 based triple parameter reporter system to evaluate TCR functions and adoptive T cell strategies Sandra Rosskopf, Judith Leitner, Wolfgang Paster, Oncotarget Adaptive Immune SystemImmunologyImmune RegulationImmunodominanceImmunoediting	2018	100
Antibody-mediated delivery of viral epitopes to tumors harnesses CMV-specific T cells for cancer therapy David G. Millar, Rakesh R. Ramjiawan, Kosuke Kawaguchi, Nature Biotechnology Tumor ImmunologyCmv-specific T CellsCancer ImmunosurveillanceAntibody-mediated DeliveryImmunology	2020	79
Simultaneous Deletion of Endogenous TCRαβ for TCR Gene Therapy Creates an Improved and Safe Cellular Therapeutic Laura T. Morton, Rogier M. Reijmers, Anne K. Wouters, Molecular Therapy	2019	67
T cell receptor engineering of primary NK cells to therapeutically target tumors and tumor immune evasion Laura T. Morton, Tassilo L A Wachsmann, Miranda H. Meeuwsen, Journal for ImmunoTherapy of Cancer	2022	27
A broad and systematic approach to identify B cell malignancy-targeting TCRs for multi-antigen-based T cell therapy Miranda H. Meeuwsen, Anne K. Wouters, Lorenz Jahn, Molecular Therapy	2021	16
Human iPSC-derived preclinical models to identify toxicity of tumor-specific T cells with clinical potential Rosa A. van Amerongen, Laura T. Morton, Umesh Chaudhari, Molecular Therapy — Methods & Clinical Development	2023	14
Identification of Functional HLA-A*01:01–Restricted Epstein-Barr Latent Membrane Protein 2–Specific T-Cell Receptors Wesley Huisman, Ilse Gille, Lieve E. van der Maarel, The Journal of Infectious Diseases	2020	11

Page 1